Objectives: To evaluate the current accuracy of CT for diagnosing benign renal tumors. Materials and Methods: We retrospectively reviewed 905 patients who underwent preoperative CT followed by surgical resection. The final pathology was benign in 156 patients (17%). After exclusions, 140 patients with 163 benign tumors were included and 3 sets of the CT interpretations by radiologists with varying levels of experience were analyzed. Results: The histological breakdown was as follows: oncocytomas (54.6%), angiomyolipomas (AMLs; 30.7%), renal cysts (8.0%), other miscellaneous benign tumors (6.7%). The sensitivities of diagnosing oncocytomas were 3.4, 9.0, and 13.5% in primary radiological reports, second blinded reviews, and third non-blinded reviews, respectively (p = 0.055). The sensitivities of diagnosing AMLs were 46.0, 58.0, and 62.0% in the 3-sets of CT interpretations, respectively (p = 0.246). As for renal cysts, the sensitivities were 69.2, 92.3, and 100% in the 3-sets of CT interpretations, respectively (p = 0.051). In primary reports, the positive predictive values were 95.8% in lipid poor (lp)-AMLs, 60.0% in oncocytomas, 69.2% in renal cysts, respectively (p < 0.05). Conclusions: Current conventional CT imaging still has limitations in differentiating oncocytomas and lp-AMLs from renal cell carcinomas, even when images were re-examined by experienced radiologists.

Keywords:
Renal tumor, Benign tumor, CT, Angiomyolipoma, Oncocytoma
1.
Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A: EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015;67:913-924.
2.
Volpe A, Kachura JR, Geddie WR, Evans AJ, Gharajeh A, Saravanan A, Jewett MA: Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 2007;178:379-386.
3.
Gill IS, Aron M, Gervais DA, Jewett MA: Clinical practice. Small renal mass. N Engl J Med 2010;362:624-634.
4.
Silverman SG, Mortele KJ, Tuncali K, Jinzaki M, Cibas ES: Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation. Radiographics 2007;27:1131-1143.
5.
Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, Matin SF, Polascik TJ, Zargar-Shoshtari K, Thompson RH: Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol 2016;69:116-128.
6.
Borghesi M, Brunocilla E, Volpe A, Dababneh H, Pultrone CV, Vagnoni V, La Manna G, Porreca A, Martorana G, Schiavina R: Active surveillance for clinically localized renal tumors: an updated review of current indications and clinical outcomes. Int J Urol 2015;22:432-438.
7.
Volpe A, Cadeddu JA, Cestari A, Gill IS, Jewett MA, Joniau S, Kirkali Z, Marberger M, Patard JJ, Staehler M, Uzzo RG: Contemporary management of small renal masses. Eur Urol 2011;60:501-515.
8.
Choudhary S, Rajesh A, Mayer NJ, Mulcahy KA, Haroon A: Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol 2009;64:517-522.
9.
Hindman N, Ngo L, Genega EM, Melamed J, Wei J, Braza JM, Rofsky NM, Pedrosa I: Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology 2012;265:468-477.
10.
Corcoran AT, Russo P, Lowrance WT, Asnis-Alibozek A, Libertino JA, Pryma DA, Divgi CR, Uzzo RG: A review of contemporary data on surgically resected renal masses - benign or malignant? Urology 2013;81:707-713.
11.
Vasudevan A, Davies RJ, Shannon BA, Cohen RJ: Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy. BJU Int 2006;97:946-949.
12.
Park SY, Jeon SS, Lee SY, Jeong BC, Seo SI, Lee HM, Choi HY: Incidence and predictive factors of benign renal lesions in Korean patients with preoperative imaging diagnoses of renal cell carcinoma. J Korean Med Sci 2011;26:360-364.
13.
Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG; Practice Guidelines Committee of the American Urological Association: Guideline for management of the clinical T1 renal mass. J Urol 2009;182:1271-1279.
14.
Ramamurthy NK, Moosavi B, McInnes MD, Flood TA, Schieda N: Multiparametric MRI of solid renal masses: pearls and pitfalls. Clin Radiol 2015;70:304-316.
15.
Bertolotto M, Cicero C, Perrone R, Degrassi F, Cacciato F, Cova MA: Renal masses with equivocal enhancement at CT: characterization with contrast-enhanced ultrasound. AJR Am J Roentgenol 2015;204:W557-W565.
16.
King KG, Gulati M, Malhi H, Hwang D, Gill IS, Cheng PM, Grant EG, Duddalwar VA: Quantitative assessment of solid renal masses by contrast-enhanced ultrasound with time-intensity curves: how we do it. Abdom Imaging 2015;40:2461-2471.
17.
Gulati M, King KG, Gill IS, Pham V, Grant E, Duddalwar VA: Contrast-enhanced ultrasound (CEUS) of cystic and solid renal lesions: a review. Abdom Imaging 2015;40:1982-1996.
18.
Volpe A, Mattar K, Finelli A, Kachura JR, Evans AJ, Geddie WR, Jewett MA: Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol 2008;180:2333-2337.
19.
Hu R, Montemayor-Garcia C, Das K: Role of percutaneous needle core biopsy in diagnosis and clinical management of renal masses. Hum Pathol 2015;46:570-576.
20.
Caoili EM, Davenport MS: Role of percutaneous needle biopsy for renal masses. Semin Intervent Radiol 2014;31:20-26.
21.
Prince J, Bultman E, Hinshaw L, Drewry A, Blute M, Best S, Lee FT Jr, Ziemlewicz T, Lubner M, Shi F, Nakada SY, Abel EJ: Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings. J Urol 2015;193:1899-1904.
22.
Pallwein-Prettner L, Flöry D, Rotter CR, Pogner K, Syré G, Fellner C, Frauscher F, Aigner F, Krause FS, Fellner F: Assessment and characterisation of common renal masses with CT and MRI. Insights Imaging 2011;2:543-556.
23.
Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS: Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 2013;267:444-453.
24.
Bissler JJ, Kingswood JC: Renal angiomyolipomata. Kidney Int 2004;66:924-934.
25.
Yang CW, Shen SH, Chang YH, Chung HJ, Wang JH, Lin AT, Chen KK: Are there useful CT features to differentiate renal cell carcinoma from lipid-poor renal angiomyolipoma? AJR Am J Roentgenol 2013;201:1017-1028.
26.
Smith AD, Remer EM, Cox KL, Lieber ML, Allen BC, Shah SN, Herts BR: Bosniak category IIF and III cystic renal lesions: outcomes and associations. Radiology 2012;262:152-160.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.